Oxonic acid is a triazine derivative and antineoplastic agent utilized primarily in the research of cancer treatments, including leukemia and lymphoma, by inhibiting purine synthesis to disrupt DNA replication… Read more
Oxonic acid is a triazine derivative and antineoplastic agent utilized primarily in the research of cancer treatments, including leukemia and lymphoma, by inhibiting purine synthesis to disrupt DNA replication in rapidly dividing cells. Laboratories rely on a comprehensive range of high-quality reference standards for this compound, including oxonic acid potassium salt, to ensure accuracy in pharmaceutical development. The inclusion of structurally characterized impurities, such as 5-azauracil, supports essential impurity profiling and method validation workflows, allowing chemists to accurately identify and quantify trace substances. Furthermore, stable isotope labelled compounds are available to serve as reliable internal standards in mass spectrometry-based assays, facilitating precise quantification and reducing matrix effects. These analytical tools are fundamental for maintaining rigorous quality control standards throughout the development and manufacturing processes of oxonic acid-related drug products.